Matthew Tunbridge

6PUBLICATIONS
29CO-AUTHORS
Molecular targetsTransplantation immunologyCharacterisation of biological macromoleculesPredictive and prognostic markersAnalytical spectrometry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 22, 2025
Mechanistic Target of Rapamycin Inhibitors and Vaccine Response in Kidney Transplant Recipients.

Griffith B Perkins, Matthew J Tunbridge, Cheng Sheng Chai

|Feb 07, 2023
SARS-CoV-2 seropositivity in renal transplant patients administered intravenous immunoglobulin.

Beatrice Z Sim, Bernice L Sim, Matthew J Tunbridge

|Nov 01, 2022
Examining the Characteristics of Colchicine-Induced Myelosuppression in Clinical Cases: A Systematic Review.

Bernice L Sim, Beatrice Z Sim, Matthew Tunbridge

|Sep 15, 2022
Rapamycin and inulin for booster vaccine response stimulation (RIVASTIM)-rapamycin: study protocol for a randomised, controlled trial of immunosuppression modification with rapamycin to improve SARS-CoV-2 vaccine response in kidney transplant recipients.

Matthew Tunbridge, Griffith B Perkins, Julian Singer

|Aug 16, 2022
Sodium chlorite poisoning: a case of severe methaemoglobinaemia and dialysis-requiring kidney injury.

Matthew Tunbridge, Shaun Chandler, Nicole Isbel

|Jul 18, 2022
COVID vaccination can be performed in patients with a history of allergic reactions to the vaccines or their components: experience from a specialist clinic in South Australia.

Matthew Tunbridge, Griffith Perkins, Maverick Lee

Pageof 1

Frequent Collaborators

3 joint publications

Beatrice Z Sim

2 joint publications

Bernice L Sim

2 joint publications

Griffith Boord Perkins

1 joint publications

Patrick Toby Coates